Drreddys Laboratories | RDY - Vermögenswerte





Vermögenswerte Veränderung Datum
ANI Pharmaceuticals USD 1.44B 32.22M 2025-12
Aurora Cannabis CAD 775.29M 18.43M 2025-12
Bayer EUR 104.54B 331M 2025-12
Canopy Growth CAD 1.11B 36.35M 2025-12
Cipla INR 401.64B 27.77B 2025-09
Corcept Therapeutics USD 836.65M 13.04M 2025-12
Drreddys Laboratories INR 6.26B 161.9M 2025-12
GlaxoSmithKline GBP 61.12B 221M 2025-12
Hikma Pharmaceutical USD 5.67B 117M 2025-12
Lonza CHF 18.97B 164M 2025-12
Novartis USD 110.95B 3.66B 2025-12
Pacira USD 1.26B 32.66M 2025-12
Phibro Animal Health USD 1.41B 20.03M 2025-12
Prestige Brands USD 3.49B 52.46M 2025-12
Richter Gedeon HUF 1.68T 39.69B 2025-12
Sun Pharmaceuticals INR 1.04T 116.06B 2025-09
Supernus Pharmaceuticals USD 1.45B 32.89M 2025-12
Teva Pharmaceutical Industries USD 40.75B 892M 2025-12